Sebastian de Nys - Chief Medical Doctor, D-Maiora Health

Feedback from Sebastian’s ex-colleagues

Let me see

Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app

Network Power<100 people

Roles

🔥50%

Startup Founder

✨50%

Business Owner

📝50%

Influencer or Blogger

Geos

🇲🇽50%

Mexico

🇺🇸50%

United States

Work Background

Diabetes ClinicDirector

Jan. 2020Mexico City, MexicoResponsible for the creation, development, expansion and direction of my private practice in Mexico City; as well as planning and executing innovative strategies for health care, with the main objective of creating awareness and communicating the importance of adherence to treatment in patients with chronic diseases (Diabetes) and simultaneously defining business strategies that allow a sustained increase in participation. market. Main achievements: ∆ Entrepreneurship of your own business currently with 150+ regular patients ∆ Establishment of personalized strategies based on the belief that "There are patients, not diseases" to optimize Diabetes treatment, resulting in adherence in 80% of cases and achieving total remission of the disease in 5 patients. ∆ Annual growth of 17.5% after the first year of operations. ∆ Implementation of 3 preventive health and vaccination campaigns to prevent seasonal diseases

Queen's University BelfastGraduate Research Assistant

Jan. 2020Belfast, United KingdomResponsible for reaserching the application of vascular organoids for the treatment of micro and macrovascular complications for patients with Type 2 Diabetes by implementing cell reprogramming protocols to obtain stem cells from mononuclear blood tissue and redifferentiate them to vascular tissue, in addition to identifying and develop protocols to expand the application to other diseases. Major Achievements ∆ Successful creation of vascular organoids that, when implanted in biological models with induced ischemia, regenerate damaged tissue and improve circulation by up to 90% ∆ Design of a research protocol combining 3D printing technology with Organoids Vaculae for the creation of neovasculature that can later be implanted in biological models. ∆ Design of a clinical trial based on the creation of stem cell-coated stents for the treatment of acute coronary disease.